Medicine guide
EchoGen
·
- Prescription status not stated
- Everything that fits nowhere else, such as contrast media
- Active substance
- Dodecafluoropentane
- Made by
- Sonus Pharmaceuticals Ltd.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- EchoGen is a transpulmonary echocardiographic contrast agent for use in patients with suspected or established cardiovascular disease to provide opacification of cardiac chambers, enhance left ventricular border delineation with resulting improvement in wall motion visualisation. EchoGen should only be used in patients where the study without contrast enhancement is inconclusive.
From the official label · 2026-09-30 · European Medicines Agency
Details
| Made by | Sonus Pharmaceuticals Ltd. |
|---|---|
| Active substance | Dodecafluoropentane |
| Used in | Everything that fits nowhere else, such as contrast media |
| Classification | V08DA · Everything that fits nowhere else, such as contrast media |
| Authorised on | 1998-07-17 |
| Last updated by the regulator | 2001-05-22 |
| EMA product number | EMEA/H/C/000149 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).